# OPEN LABEL, 2-PERIOD STUDY, TO COMPARE BIO-AVAILABILITY OF 2 DIFFERENT FORMULATIONS OF PF-05221304 IN HEALTHY ADULTS

> **NCT03871439** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-05221304 Formulation A
- **DRUG:** PF-05221304 Formulation B

## Key facts

- **NCT ID:** NCT03871439
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-13
- **Primary completion:** 2019-05-08
- **Final completion:** 2019-05-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03871439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03871439, "OPEN LABEL, 2-PERIOD STUDY, TO COMPARE BIO-AVAILABILITY OF 2 DIFFERENT FORMULATIONS OF PF-05221304 IN HEALTHY ADULTS". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT03871439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*